{"id":153109,"date":"2023-08-11T12:09:50","date_gmt":"2023-08-11T16:09:50","guid":{"rendered":"https:\/\/44.250.171.167\/?p=153109"},"modified":"2023-08-11T12:09:51","modified_gmt":"2023-08-11T16:09:51","slug":"bafna-pharmaceuticals-ltd-q1fy24-367-rise-in-profits","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/bafna-pharmaceuticals-ltd-q1fy24-367-rise-in-profits\/","title":{"rendered":"Bafna Pharmaceuticals Ltd Q1FY24; 367% rise in Profits"},"content":{"rendered":"\n<p>Bafna Pharmaceuticals is engaged in the Business of manufacture of pharmaceutical products.<\/p>\n\n\n\n<p style=\"font-size:24px\"><strong>Financial Results:<\/strong><\/p>\n\n\n\n<p>Bafna Pharmaceuticals Ltd reported Revenues for Q1FY24 of \u20b941.95 Crores up from \u20b916.93 Crore year on year, a rise of 147.78%.<\/p>\n\n\n\n<p>Total Expenses for Q1FY24 of \u20b937.47 Crores up from \u20b916.87 Crores year on year, a rise of 122.11%.<\/p>\n\n\n\n<p>Consolidated Net Profit of \u20b96.35 Crores up 366.91% from \u20b91.36 Crores in the same quarter of the previous year.<\/p>\n\n\n\n<p>The Earnings per Share is \u20b92.68, up 370.18% from \u20b90.57 in the same quarter of the previous year.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"839\" height=\"1024\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-810-839x1024.png\" alt=\"\" class=\"wp-image-153110\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-810-839x1024.png 839w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-810-246x300.png 246w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-810-768x937.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-810-1259x1536.png 1259w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-810.png 1489w\" sizes=\"auto, (max-width: 839px) 100vw, 839px\" \/><\/figure>\n\n\n\n<p>*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.<\/p>\n\n\n\n<p>*The presented data is automatically generated. It may occasionally generate incorrect information.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Bafna Pharmaceuticals is engaged in the Business of manufacture of pharmaceutical products. Financial Results: Bafna Pharmaceuticals Ltd reported Revenues for Q1FY24 of \u20b941.95 Crores up from \u20b916.93 Crore year on year, a rise of 147.78%. Total Expenses for Q1FY24 of \u20b937.47 Crores up from \u20b916.87 Crores year on year, a rise of 122.11%. Consolidated Net [&hellip;]<\/p>\n","protected":false},"author":1932,"featured_media":153110,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392],"tags":[1115],"class_list":["post-153109","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","tag-pharmaceuticals"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-810.png","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":151180,"url":"https:\/\/alphastreet.com\/india\/alembic-pharmaceuticals-ltd-q1fy24-18-rise-in-revenue\/","url_meta":{"origin":153109,"position":0},"title":"Alembic Pharmaceuticals Ltd Q1FY24; 18% rise in Revenue.","author":"Divyansh_Kasana","date":"August 4, 2023","format":false,"excerpt":"Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients.The company has 3 R&D and 5 manufacturing facilities. Financial Results: Alembic Pharmaceuticals Ltd reported Revenues for Q1FY24 of \u20b91,486.00 Crores up from \u20b91,262.00 Crore year on year, a rise of\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-168.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-168.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-168.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-168.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-168.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-168.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":153153,"url":"https:\/\/alphastreet.com\/india\/glenmark-pharmaceuticals-ltd-q1fy24-18-fall-in-profits\/","url_meta":{"origin":153109,"position":1},"title":"Glenmark Pharmaceuticals Ltd Q1FY24; 18% fall in Profits","author":"Hardik Bhandare","date":"August 14, 2023","format":false,"excerpt":"Glenmark Pharmaceuticals Ltd is a global research-led pharmaceutical company with presence across generics, Specialty and OTC business with operations in over 80 countries. Financial Results: Glenmark Pharmaceuticals Ltd reported Revenues for Q1FY24 of \u20b93,402.00 Crores up from \u20b92,777.00 Crore year on year, a rise of 22.51%. Total Expenses for Q1FY24\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-823.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-823.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-823.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-823.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-823.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-823.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":151727,"url":"https:\/\/alphastreet.com\/india\/sms-pharmaceuticals-ltd-q1fy24-110-rise-in-revenue\/","url_meta":{"origin":153109,"position":2},"title":"SMS Pharmaceuticals Ltd Q1FY24; 110% rise in Revenue","author":"Chirag Gupta","date":"August 8, 2023","format":false,"excerpt":"SMS Pharmaceuticals Ltd is a diversified and integrated pharmaceutical company with interests in Active Pharmaceutical Ingredients (API) and Intermediates. Financial Results: SMS Pharmaceuticals Ltd reported Revenues for Q1FY24 of \u20b9135.34 Crores up from \u20b964.39 Crore year on year, a rise of 110.19%. Total Expenses for Q1FY24 of \u20b9123.17 Crores up\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-351.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-351.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-351.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-351.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-351.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-351.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":151515,"url":"https:\/\/alphastreet.com\/india\/torrent-pharmaceuticals-ltd-q1fy24-7-rise-in-profits\/","url_meta":{"origin":153109,"position":3},"title":"Torrent Pharmaceuticals Ltd Q1FY24; 7% rise in Profits","author":"Chirag Gupta","date":"August 7, 2023","format":false,"excerpt":"Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations. Financial Results: Torrent Pharmaceuticals Ltd reported Revenues for Q1FY24 of \u20b92,591.00 Crores up from \u20b92,347.00 Crore year on year, a rise of 10.4%. Total Expenses for Q1FY24 of\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-281.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-281.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-281.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-281.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-281.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-281.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":151914,"url":"https:\/\/alphastreet.com\/india\/suven-pharmaceuticals-ltd-q1fy24-12-rise-in-profits\/","url_meta":{"origin":153109,"position":4},"title":"Suven Pharmaceuticals Ltd Q1FY24; 12% rise in Profits","author":"Chirag Gupta","date":"August 9, 2023","format":false,"excerpt":"Suven Pharma is in the business of Contract development & manufacturing organisation (CDMO), catering to the needs of global Pharma Industry. Financial Results: Suven Pharmaceuticals Ltd reported Revenues for Q1FY24 of \u20b9348.00 Crores up from \u20b9339.00 Crore year on year, a rise of 2.65%. Total Expenses for Q1FY24 of \u20b9195.00\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-415.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-415.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-415.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-415.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-415.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-415.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":150942,"url":"https:\/\/alphastreet.com\/india\/jagsonpal-pharmaceuticals-ltd-q1fy24-156-rise-in-profits\/","url_meta":{"origin":153109,"position":5},"title":"Jagsonpal Pharmaceuticals Ltd Q1FY24; 156% rise in Profits","author":"Hardik Bhandare","date":"August 2, 2023","format":false,"excerpt":"Jagsonpal Pharmaceuticals Ltd is primarily engaged in the manufacturing and trading of pharmaceutical products and APIs. It has operations in India and caters to both domestic and international markets. Financial Results: Jagsonpal Pharmaceuticals Ltd reported Revenues for Q1FY24 of \u20b960.15 Crores down from \u20b960.60 Crore year on year, a fall\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-93.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-93.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-93.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-93.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-93.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-93.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/153109","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1932"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=153109"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/153109\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/153110"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=153109"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=153109"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=153109"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}